ChemBridge Corporation is engaged in the research, development, and production of custom libraries on an exclusive basis for selected partners. Such libraries leverage the advanced chemistry-focused proprietary technology platform, which was first developed by ChemBridge for the PHARMACophore library. This platform now matches the most challenging quality standards of the world's leading pharmaceutical companies and enables us to deliver custom libraries within our partners’ demanding timelines.
Our advanced and flexible chemistry-focused proprietary technology platform enables us to utilize effectively our synthetic, medicinal, and computational chemistry resources to successfully design and produce a wide range of diverse, targeted, focused libraries or follow-up libraries. We are able to generate libraries to all our partners’ varied requirements of scale, purity, and formats.
ChemBridge has established itself a premier provider of custom library services, having signed into major multi-year agreements to develop and supply exclusive custom combinatorial libraries to Pfizer, Inc., Merck & Co., Inc., AstraZeneca and many others. Our successful track record provides further proof of the value of our technology and capabilities.
For more information, contact sales@chembridge.com
top of the page |
